Epithelial Ovarian Cancer

作者: Stephanie Lheureux , Charlie Gourley , Ignace Vergote , Amit M Oza

DOI: 10.1016/S0140-6736(18)32552-2

关键词:

摘要: Ovarian cancer is the seventh most common in women worldwide; ovarian a disease of older with majority (>80 %) cases diagnosed over 50 years. The median age patients somewhat lower many developing countries because their population structure. symptoms are nonspecific. not single entity but represents tumors epithelial (>90 %), germ cell, or sex cord stromal origin. staged surgically pathologic confirmation. Appropriate surgery paramount importance for correct staging, planning adjuvant treatment, and prognostication. In advanced cancer, aim to achieve optimal cytoreduction, currently defined as complete resection all disease. current broad consensus that paclitaxel-platinum standard first-line regimen cancer. various management options based on resource considerations discussed.

参考文章(163)
Roland F. Schwarz, Charlotte K. Y. Ng, Susanna L. Cooke, Scott Newman, Jillian Temple, Anna M. Piskorz, Davina Gale, Karen Sayal, Muhammed Murtaza, Peter J. Baldwin, Nitzan Rosenfeld, Helena M. Earl, Evis Sala, Mercedes Jimenez-Linan, Christine A. Parkinson, Florian Markowetz, James D. Brenton, Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis PLOS Medicine. ,vol. 12, pp. e1001789- ,(2015) , 10.1371/JOURNAL.PMED.1001789
Richard G. Moore, D. Scott McMeekin, Amy K. Brown, Paul DiSilvestro, M. Craig Miller, W. Jeffrey Allard, Walter Gajewski, Robert Kurman, Robert C. Bast, Steven J. Skates, A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass Gynecologic Oncology. ,vol. 112, pp. 40- 46 ,(2009) , 10.1016/J.YGYNO.2008.08.031
Wen-Juan Tian, Dennis S. Chi, Jalid Sehouli, Claes G. Tropé, Rong Jiang, Ali Ayhan, Gennaro Cormio, Yan Xing, Georg-Peter Breitbach, Elena Ioana Braicu, Catherine A. Rabbitt, Halldis Oksefjell, Christina Fotopoulou, Hans-Gerd Meerpohl, Andreas du Bois, Jonathan S. Berek, Rong-Yu Zang, Philipp Harter, A Risk Model for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer: An Evidence-Based Proposal for Patient Selection Annals of Surgical Oncology. ,vol. 19, pp. 597- 604 ,(2012) , 10.1245/S10434-011-1873-2
Chhanda Bewtra, Patrice Watson, Teresa Conway, Connie Read-Hippee, Henry T. Lynch, Hereditary ovarian cancer: a clinicopathological study. International Journal of Gynecological Pathology. ,vol. 11, pp. 180- 187 ,(1992) , 10.1097/00004347-199207000-00003
Alan N. Gordon, Michael Teneriello, Mike F. Janicek, Jeffrey Hines, Peter C. Lim, M. Dwight Chen, Luis Vaccarello, Howard D. Homesley, Scott McMeekin, Tiana L. Burkholder, Yanping Wang, Luping Zhao, Mauro Orlando, Coleman K. Obasaju, John F. Gill, Datchen F. Tai, Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer. Gynecologic Oncology. ,vol. 123, pp. 479- 485 ,(2011) , 10.1016/J.YGYNO.2011.08.018
Clare R. Bankhead, Sean T. Kehoe, Joan Austoker, Symptoms associated with diagnosis of ovarian cancer: A systematic review British Journal of Obstetrics and Gynaecology. ,vol. 112, pp. 857- 865 ,(2005) , 10.1111/J.1471-0528.2005.00572.X
John K. Chan, Chunqiao Tian, Gini F. Fleming, Bradley J. Monk, Thomas J. Herzog, Daniel S. Kapp, Jeffrey Bell, The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: An exploratory analysis of a Gynecologic Oncology Group study Gynecologic Oncology. ,vol. 116, pp. 301- 306 ,(2010) , 10.1016/J.YGYNO.2009.10.073
Alison M. Karst, Ronny Drapkin, Ovarian Cancer Pathogenesis: A Model in Evolution Journal of Oncology. ,vol. 2010, pp. 932371- 932371 ,(2010) , 10.1155/2010/932371
R. C. Young, Early-Stage Ovarian Cancer: To Treat or Not To Treat Journal of the National Cancer Institute. ,vol. 95, pp. 94- 95 ,(2003) , 10.1093/JNCI/95.2.94
Wei-Ting Hwang, Sarah F. Adams, Emin Tahirovic, Ian S. Hagemann, George Coukos, Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis Gynecologic Oncology. ,vol. 124, pp. 192- 198 ,(2012) , 10.1016/J.YGYNO.2011.09.039